CRFS: At home on the (test) range
CRFS, a global leader in RF spectrum monitoring, management and geolocation solutions, today announces the launch of its automated spectrum monitoring tool set, RFeye Mission.
TAP enters Australasian market
Edtech peer-to-peer platform The Access Platform has announced its entry into the Australasian international education market as it secured contracts with universities in the region.
GeoSpock helps build gamechanging ‘green’ resource for global shipping
Cambridge-based extreme data technology business GeoSpock is helping to build a new digital resource to help the global maritime industry literally clean up its act.
Eagle Genomics Soars into the Big Apple
The company launches in NYC with a panel discussion asking "will the microbiome revolution happen?"
Is This AI The Ultimate Security Guard?
A small company based in Cambridge, England, is teaching machines to hear, with the aim of boosting devices' capabilities in protecting their users.
Crayfish.io adds funding capability to strategic armoury to help Cambridge startups woo China
Cambridge startup Crayfish.io is focusing its expanding business on three core categories as it establishes itself as the full service provider for business engagement with China.
Nepal joins clamour for anti-pollution masks
Responding to the global air quality crisis, a Cambridge-based business has won £5.5 million in overseas business to countries like Nepal.
Paragraf and Queen Mary University awarded £500,000 to explore the use of graphene to replace rare metal Indium
Paragraf, which recently raised $16 million USD to push forward graphene-based electronics technologies, and Queen Mary University of London have been awarded £500,000 (around $623,000 USD) by Innovate UK to explore using graphene to replace the rare metal Indium.
Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion
We are pleased to announce the appointment of Neil Thompson, PhD, as Chief Scientific Officer (CSO)
All the winners and the pictures from the SME Cambridgeshire Business Awards 2019
The finest small and medium-sized enterprises in the county were recognised at the annual SME Cambridgeshire Business Awards, where it was revealed that the Cambridge Independent will be taking over the event next year.
Paragraf raises £12.8m to deliver its first graphene-based electronics technologies
UK-founded graphene-based electronics technology company Paragraf announces today the close of its £12.8m Series A round. The funding, led by Parkwalk, will fuel product development as the company commercialises.
Ion mighty: Controllis launches powerful new comms technology
Critical telecoms and off-grid sites can now gain significant performance and cost improvements by switching to state-of-the-art lithium-ion batteries through new technology launched by expanding Cambridge and Thetford hybrid power systems specialist Controllis.
CCS welcomes opening up of 60GHz mmWave unlicensed band for gigabit fixed wireless access (FWA) in Europe
New CEPT ECC recommendations pave the way for ubiquitous deployment of unlicensed 60GHz technology – including EU Type Approved CCS Metnet 60G mmWave Solution.
Repositive makes world-leading directory of 5,300 preclinical cancer models publicly browsable as first stage of platform relaunch
Repositive, the Cambridge-based startup that connects researchers with the right preclinical cancer models to enhance their drug development programmes, has made its world-leading directory of preclinical cancer models publicly browsable as the first stage of relaunching its Cancer Models Platform.
Mental Health under the microscope in Cambridge
Cambridge’s global pre-eminence in creating digital techniques to combat mental illness will be showcased at the next Business Weekly-Mills & Reeve Life Science Forum on July 24.
How social media predicts publisher Unbound's next bestseller
London-based tech start-up founded by author of 'Crap Towns' recently secured £840,000 in crowdfunding
£8m drug-resistance grant for Oxford Drug Design
Oxford Drug Design has received over £8 million in grant and equity investment from CARB-X, the UK Department of Health and Social Care (DHSC) and o2h Ventures.
Deliveroo partners with Cambridge Mask Company to tackle UK pollution
Deliveroo marked Clean Air Day by teaming up with Cambridge Mask Company in an initiative that saw free anti-pollution masks handed out to thousands of cyclists at pollution hot spots in four of the UK’s worst affected cities – London, Manchester, Birmingham and Glasgow.
Asia major as data doyen GeoSpock opens Tokyo and Singapore offices
Cambridge extreme data technology business GeoSpock is leveraging growing demand in Asia by opening operations in Tokyo and Singapore. It plans to hire 30 staff in Asia in the next 24 months.
Cambridge extreme data technology business GeoSpock is leveraging growing demand in Asia by opening operations in Tokyo and Singapore. It plans to hire 30 staff in Asia in the next 24 months.
The move hands GeoSpock a springboard to broaden services to new and existing clients in both regions. These include the Singapore Land Authority and X-locations, a Japanese-based artificial intelligence platform.
The UK specialist is mining fresh opportunities for growth within vertical markets such as smart cities, IoT, enterprise, asset and logistics.
Singapore will operate as the company’s Asian headquarters and enable GeoSpock to respond to the rapid growth in demand for robust data infrastructures that can support innovation.
Richard Baker, CEO of GeoSpock, said: “The world’s population is set to grow by 2.2 billion between now and 2050 with 60 per cent of the global population living in Asia. As a result, we anticipate this is where we will see the largest growth in the Internet of Things and its associated sensors.
“However, to prepare for an increasingly connected world, organisations need a platform that can uncover insights within data to inform business decisions. As part of our expansion into Asia we will use our expertise to support geospatial initiatives and the advancement of IoT technologies.”
To drive the initiative, Sean Kim has been appointed as vice-president of Asia and will be responsible for growing brand advocacy and revenues. Sean Kim is an experienced industry sales leader with nearly 30 years’ experience in launching and expanding technology businesses in the Asia-Pacific including companies such as AirTies, Technicolor, ANT and Nagravision.
Sean Kim will be supported by the appointment of John Yam who will lead the Singapore office and Motohiro Watanbe who will manage the office in Japan. To help drive its ambition to become the leader in spatial big data management and analytics in the region, GeoSpock plans to add up to 30 people in commercial, technical and data science roles in Asia over the next two years.
“Across Asia, developments in infrastructure and smart cities are driving the need for access to dynamic contextual data. GeoSpock’s technology is at the cutting edge of spatial big data and meets this demand,” said Sean Kim, VP of Asia. “I expect GeoSpock to contribute hugely to the geospatial market both in Asia and around the world.”
GeoSpock brings sensor data to life – translating complex connections into meaningful visualisations that reveal the bigger picture.
Its platform has the power to transform lives and businesses – whether it's cutting harmful emissions by reducing traffic congestion or maximising profitability by optimising commercial operations.
In seconds, GeoSpock harnesses trillions of data points to discover hidden patterns and create a valuable new perspective in markets ranging from maritime and logistics to smart cities and data technology.
£550,000 funding will help Qkine to establish Cambridge Science Park base
Qkine has secured £550,000 in funding to establish a UK manufacturing base on Cambridge Science Park and expand its research and development activities.
The company, which has moved from Merlin Place in Milton Road, Cambridge, into Building 152 beside the Bradfield Centre, is a specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications.
The funding round was led by Cambridge Enterprise and five angel investors, all of whom were following up initial seed investments made in April 2018.
Dr Andy Richards, the biotech entrepreneur and founder member of the Cambridge Angels, has joined them in backing the company, which was spun out of the University of Cambridge in 2010 and is led by Catherine Elton.
Its proprietary technologies and protein engineering techniques help it to produce exceptionally high purity growth factors and cytokines.
Its products can be used by stem cell researchers, who can use them for modelling of diseases, to aid the drive towards precision medicine and develop new therapeutics.
And they can be used by scientists working with organoids to help us understand human biology better and test drug candidates.
Dr Richards said: "Catherine and team have done a great job at Qkine. I am excited to join their investors in this round as they move to their new facility, scale up their team, extend their R&D pipeline and expand their commercial ambitions.
“The need for quality and reproducibility in stem cell biology and exciting new areas such as organoids is driving a growing market that Qkine is uniquely positioned to satisfy."
Qkine will expand its research team and develop its R&D pipeline with the money, while accelerating the commercialisation of its products with a new manufacturing base.
Jim Warwick, angel investor and chairman of Qkine said: “Following my initial investment in Qkine was a no-brainer - its growth factors are developed from a genuinely differentiating technology.
“The market for these reagents is growing rapidly and the company’s founders have great, complementary skill sets.”
The company helps solve scientific challenges for researchers such as structural heterogeneity, poor stability and solubility and spurious interactions with other biomolecules, meaning it can provide more reliable tools for research and bio-manufacturing.
Dr Christine Martin, investment manager (life sciences) at Cambridge Enterprise, who joins the board, said: “Cambridge Enterprise is pleased to support Qkine as it takes its next steps. The need for high quality cytokines and growth factors continues to expand, and Qkine is poised to meet the demand with a catalogue of products to support research into stem cell, organoid and regenerative medicine applications.”